Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Proteomics International Begins National Rollout Of Promarker Tests Through Healius

PIQ: $0.120 +2.13% · MC: $16M

Proteomics International has begun a national rollout of Promarker D and Promarker Eso through Healius, following their controlled release in Western Australia and the Northern Territory. It reported quarterly operating cash outflows of approximately $2 million and cash of approximately $2 million at quarter-end; a subsequent approximately $2 million research and development tax incentive lifted its pro forma cash position to approximately $4 million. Promarker Endo is expected to become commercially available in FY27 Q3, subject to clinical deployment and applicable requirements.

Source announcements: 2026-10-30 17:02 to 2026-10-30 17:02 Sydney time
Story updated 2026-10-30 17:05 Sydney time
SourcesQuarterly Activities/Appendix 4C Cash Flow Report
Comments